
    
      An open label, randomized, single dose, 2-sequence, 4-period, cross-over clinical trial to
      evaluate the pharmacokinetics and tolerability of CKD-348 with coadministration of CKD-828,
      D097 and D337 in healthy adult volunteers
    
  